business

Moderna (MRNA) Soars 11% Ahead of Investor Day

Yahoo Finance · Jun 17, 2026, 11:57 PM · Also reported by 3 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

The Hill FDA vaccine panel set to review Moderna mRNA flu shot Ars Technica FDA advisors unanimously vote to approve Moderna's mRNA after agency drama STAT News STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Moderna (MRNA) Soars 11% Ahead of Investor Day

Also covered by

More in business